Literature DB >> 3188318

Primary adenocarcinoma of seminal vesicle presenting as bladder tumor.

N S Davis1, P A Merguerian, P L DiMarco, P M Dvoretsky, H Rashid.   

Abstract

A case of primary seminal vesicle carcinoma is described and is discussed in the context of current knowledge regarding the clinicopathologic features of this rare neoplasm.

Entities:  

Mesh：

Year:  1988        PMID： 3188318     DOI： 10.1016/0090-4295(88)90429-3

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  6 in total

1.  An unusual cause of hematospermia: Primary adenocarcinoma of the seminal vesicle.

Authors:  Alper Eken; Volkan Izol; I Atilla Aridogan; Seyda Erdogan; Arbil Acıkalın; Zuhtu Tansug
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

2.  Metastatic primary seminal vesicle adenocarcinoma: management of a rare tumour with multiagent chemotherapy and hormonal therapy.

Authors:  Hira Lal; Priyank Yadav; Rahul Jena; Manoj Jain
Journal:  BMJ Case Rep       Date:  2017-10-10

Review 3.  Leiomyoma of the seminal vesicle.

Authors:  Takeshi Shiotani; Nobuyuki Kawai; Morio Sato; Hiroyuki Minamiguchi; Taizo Takeuchi; Hirohiko Tanihata; Kazuro Kikukawa; Yasunari Uekado; Toshiaki Shinka
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

Review 4.  Primary seminal vesicle adenocarcinoma: a lethal yet cryptic malignancy with review of literature.

Authors:  Abhishek Bhat; Indraneel Banerjee; Oleksandr N Kryvenko; Ramgopal Satyanarayana
Journal:  BMJ Case Rep       Date:  2019-12-17

5.  Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature.

Authors:  Andrzej Deptala; Agnieszka Romanowicz; Aleksandra Czerw; Jerzy Walecki; Wojciech Rogowski; Anna Nasierowska-Guttmejer
Journal:  Onco Targets Ther       Date:  2016-07-20       Impact factor: 4.147

6.  A 5-year follow-up of primary seminal vesicle adenocarcinoma: A case report.

Authors:  Tiejun Yin; Yueqiang Jiang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.